John Andrew Partridge - EVP & Chief Commercial Officer, Turning Point Therapeutics, Inc
As of July 15, 2021
John Andrew Partridge Net Worth
- Net worth is estimated to be at least $1.63M
- Owns at least 21,767 units of Turning Point Therapeutics, Inc stock
- Sold an estimated value of $139.99K in the last year at Turning Point Therapeutics, Inc
John Andrew Partridge Compensation at Turning Point Therapeutics, Inc in 2020
- Earned a $220,758 salary
- Rewarded $1,288,710 in stock value and options
- Received a total compensation of $7,226,561
John Andrew Partridge Trading
- Largest sale of shares was 1,869 units , worth over $139.99K on July 15, 2021
- In total has made about 3 transactions over a year
- Usually trades in July, with the busiest year in 2021
John Andrew Partridge
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
John Andrew Partridge Mailing Address
- Mailing address is C/o Centrexion Therapeutics Corporation 200 State Street Boston MA 02109 MA
Turning Point Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Athena Countouriotis, M.D. | 2020 | $580,000 | - | - | $14,131,423 | $539,400 | $11,400 | $15,262,223 |
| Athena Countouriotis, M.D. | 2018 | $329,442 | $400,000 | $ | $7,766,667 | $158,971 | $8,690 | $8,663,770 |
| Yi Larson | 2020 | $451,688 | - | - | $1,434,883 | $255,600 | $114,716 | $2,256,887 |
| Yi Larson | 2019 | $158,523 | $360,757 | - | $11,715,012 | $283,500 | $61,633 | $12,579,425 |
| Annette North | 2020 | $400,000 | - | - | $2,434,953 | $230,400 | $11,400 | $3,076,753 |
| Annette North | 2018 | $ | $ | $ | $ | $ | $ | $ |
| Andrew Partridge | 2020 | $220,758 | - | $1,288,710 | $5,210,033 | $304,560 | $202,500 | $7,226,561 |
| Andrew Partridge | 2018 | $ | $ | $ | $ | $ | $ | $ |
| Siegfried Reich, Ph.D. | 2020 | $325,000 | - | - | $5,227,485 | $187,097 | - | $5,739,582 |
| Siegfried Reich, Ph.D. | 2018 | $ | $ | $ | $ | $ | $ | $ |
| Jingrong Jean Cui, Ph.D. | 2020 | $43,217 | - | - | $1,870,156 | - | $1,189,061 | $3,102,434 |
| Jingrong Jean Cui, Ph.D. | 2018 | $399,289 | $ | $ | $11,715,012 | $283,500 | $3,674 | $12,401,475 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1595893/000119312521117723/d27986ddef14a.htm
Turning Point Therapeutics, Inc Insider Trading
- The most recent transaction was 10,000 units sold on August 31, 2021 by Annette North worth over $800K
- In the last 2 years, insiders at Turning Point Therapeutics, Inc sold an estimated value of $71.63M and bought an estimated value of $66.53M
- The most active traders are Jean Jingrong Cui, Director, Annette North, EVP, and Athena Countouriotis, President & CEO
- Insider trading is most common in June, with the busiest year in 2020
Turning Point Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||